We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Aecom
ACM
$9.07B
| $730K | 0.01% |
19,661
-29,585
| -60% | -$1.08M |
|
|
CPRX
977
DELISTED
Catalyst Pharmaceutical
CPRX
| $730K | 0.01% |
186,643
+109,743
| +143% | +$363K |
|
|
MODN
978
DELISTED
MODEL N, INC.
MODN
| $730K | 0.01% |
+46,366
| New | +$698K |
|
979
Teladoc Health
TDOC
$1.58B
| $729K | 0.01% |
+20,911
| New | +$694K |
|
980
Beazer Homes USA
BZH
$907M
| $727K | 0.01% |
37,856
+14,656
| +63% | +$294K |
|
981
Modine Manufacturing
MOD
$12.8B
| $727K | 0.01% |
35,995
+16,954
| +89% | +$364K |
|
|
DNB
982
DELISTED
Dun & Bradstreet
DNB
| $726K | 0.01% |
6,130
-3,188
| -34% | -$378K |
|
983
EPR Properties
EPR
$4.86B
| $722K | 0.01% |
11,024
+589
| +6% | +$40.3K |
|
984
Applied Industrial Technologies
AIT
$12.8B
| $721K | 0.01% |
10,588
-11,969
| -53% | -$761K |
|
985
Axogen
AXGN
$2.1B
| $719K | 0.01% |
25,407
+15,016
| +145% | +$354K |
|
986
Herc Holdings
HRI
$5.43B
| $719K | 0.01% |
+11,477
| New | +$632K |
|
|
CLVS
987
DELISTED
Clovis Oncology, Inc.
CLVS
| $714K | 0.01% |
+10,493
| New | +$734K |
|
|
SPWR
988
DELISTED
SunPower Corporation Common Stock
SPWR
| $712K | 0.01% |
129,027
+74,342
| +136% | +$385K |
|
989
Motorola Solutions
MSI
$69.4B
| $710K | 0.01% |
7,862
-92,894
| -92% | -$8.46M |
|
|
SOHU
990
Sohu.com
SOHU
$336M
| $707K | 0.01% |
+16,300
| New | +$874K |
|
991
Williams Companies
WMB
$90.5B
| $707K | 0.01% |
23,200
-818,065
| -97% | -$23.8M |
|
992
Columbia Banking Systems
COLB
$8.81B
| $705K | 0.01% |
+16,233
| New | +$708K |
|
993
Sturm, Ruger & Co
RGR
$610M
| $705K | 0.01% |
+12,631
| New | +$659K |
|
|
MDR
994
DELISTED
McDermott International
MDR
| $704K | 0.01% |
35,640
+24,914
| +232% | +$526K |
|
995
Bausch Health
BHC
$1.65B
| $703K | 0.01% |
+33,830
| New | +$536K |
|
|
SGMO
996
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $703K | 0.01% |
+42,836
| New | +$637K |
|
997
Movado Group
MOV
$812M
| $701K | 0.01% |
21,767
+6,798
| +45% | +$197K |
|
|
WLH
998
DELISTED
WILLIAM LYON HOMES
WLH
| $700K | 0.01% |
+24,068
| New | +$651K |
|
|
NGD
999
DELISTED
New Gold Inc
NGD
| $698K | 0.01% |
212,084
-65,550
| -24% | -$220K |
|
1000
PDF Solutions
PDFS
$2.13B
| $698K | 0.01% |
+44,479
| New | +$714K |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.